867 related articles for article (PubMed ID: 18389514)
21. Prodrugs of HIV protease inhibitors-saquinavir, indinavir and nelfinavir-derived from diglycerides or amino acids: synthesis, stability and anti-HIV activity.
Gaucher B; Rouquayrol M; Roche D; Greiner J; Aubertin AM; Vierling P
Org Biomol Chem; 2004 Feb; 2(3):345-57. PubMed ID: 14747863
[TBL] [Abstract][Full Text] [Related]
22. Self-assembled drug delivery systems. Part 4. In vitro/in vivo studies of the self-assemblies of cholesteryl-phosphonyl zidovudine.
Jin Y; Xing L; Tian Y; Li M; Gao C; Du L; Dong J; Chen H
Int J Pharm; 2009 Oct; 381(1):40-8. PubMed ID: 19646518
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and in vitro activity of long-chain 5'-O-[(alkoxycarbonyl)phosphinyl]-3'-azido-3'-deoxythymidines against wild-type and AZT- and foscarnet-resistant strains of HIV-1.
Rosowsky A; Fu H; Pai N; Mellors J; Richman DD; Hostetler KY
J Med Chem; 1997 Aug; 40(16):2482-90. PubMed ID: 9258355
[TBL] [Abstract][Full Text] [Related]
24. Design and discovery of a novel dipeptidyl-peptidase IV (CD26)-based prodrug approach.
García-Aparicio C; Bonache MC; De Meester I; San-Félix A; Balzarini J; Camarasa MJ; Velazquez S
J Med Chem; 2006 Aug; 49(17):5339-51. PubMed ID: 16913724
[TBL] [Abstract][Full Text] [Related]
25. Design, synthesis, and evaluation of tripeptidic promoieties targeting the intestinal peptide transporter hPEPT1.
Thorn K; Andersen R; Christensen J; Jakobsen P; Nielsen CU; Steffansen B; Begtrup M
ChemMedChem; 2007 Apr; 2(4):479-87. PubMed ID: 17407174
[TBL] [Abstract][Full Text] [Related]
26. Probing the mechanism of action and decomposition of amino acid phosphomonoester amidates of antiviral nucleoside prodrugs.
McIntee EJ; Remmel RP; Schinazi RF; Abraham TW; Wagner CR
J Med Chem; 1997 Oct; 40(21):3323-31. PubMed ID: 9341906
[TBL] [Abstract][Full Text] [Related]
27. Pharmacokinetics of novel dipeptide ester prodrugs of acyclovir after oral administration: intestinal absorption and liver metabolism.
Anand BS; Katragadda S; Mitra AK
J Pharmacol Exp Ther; 2004 Nov; 311(2):659-67. PubMed ID: 15226381
[TBL] [Abstract][Full Text] [Related]
28. Conformational restrictions in ligand binding to the human intestinal di-/tripeptide transporter: implications for design of hPEPT1 targeted prodrugs.
Våbenø J; Nielsen CU; Steffansen B; Lejon T; Sylte I; Jørgensen FS; Luthman K
Bioorg Med Chem; 2005 Mar; 13(6):1977-88. PubMed ID: 15727852
[TBL] [Abstract][Full Text] [Related]
29. Design of new mononucleotide prodrugs: aryl (SATE) phosphotriester derivatives.
Peyrottes S; Schlienger N; Beltran T; Lefebvre I; Pompon A; Gosselin G; Aubertin AM; Imbach JL; Périgaud C
Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):315-21. PubMed ID: 11563043
[TBL] [Abstract][Full Text] [Related]
30. Derivatives of melphalan designed to enhance drug accumulation in cancer cells.
Kupczyk-Subotkowska L; Tamura K; Pal D; Sakaeda T; Siahaan TJ; Stella VJ; Borchardt RT
J Drug Target; 1997; 4(6):359-70. PubMed ID: 9239576
[TBL] [Abstract][Full Text] [Related]
31. Kinetics of degradation and oil solubility of ester prodrugs of a model dipeptide (Gly-Phe).
Larsen SW; Ankersen M; Larsen C
Eur J Pharm Sci; 2004 Aug; 22(5):399-408. PubMed ID: 15265509
[TBL] [Abstract][Full Text] [Related]
32. Serine side chain-linked peptidomimetic conjugates of cyclic HPMPC and HPMPA: synthesis and interaction with hPEPT1.
Peterson LW; Sala-Rabanal M; Krylov IS; Serpi M; Kashemirov BA; McKenna CE
Mol Pharm; 2010 Dec; 7(6):2349-61. PubMed ID: 20929265
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and antiviral activity of amino acid carbamate derivatives of AZT.
Chang SL; Griesgraber G; Abraham TW; Garg T; Song H; Zimmerman CL; Wagner CR
Nucleosides Nucleotides Nucleic Acids; 2000; 19(1-2):87-100. PubMed ID: 10772704
[TBL] [Abstract][Full Text] [Related]
34. Synthesis of poly(ethylene glycol)-based saquinavir prodrug conjugates and assessment of release and anti-HIV-1 bioactivity using a novel protease inhibition assay.
Gunaseelan S; Debrah O; Wan L; Leibowitz MJ; Rabson AB; Stein S; Sinko PJ
Bioconjug Chem; 2004; 15(6):1322-33. PubMed ID: 15546199
[TBL] [Abstract][Full Text] [Related]
35. Synthesis, anti-HIV activity, and stability studies of 5'-phosphorofluoridate derivatives of AZT.
Egron D; Arzumanov AA; Dyatkina NB; Aubertin AM; Imbach JL; Gosselin G; Krayevsky A; Périgaud C
Bioorg Chem; 2001 Dec; 29(6):333-44. PubMed ID: 11846432
[TBL] [Abstract][Full Text] [Related]
36. Application of enzymatically stable dipeptides for enhancement of intestinal permeability. Synthesis and in vitro evaluation of dipeptide-coupled compounds.
Friedrichsen GM; Jakobsen P; Taub M; Begtrup M
Bioorg Med Chem; 2001 Oct; 9(10):2625-32. PubMed ID: 11557350
[TBL] [Abstract][Full Text] [Related]
37. In vitro anti-hepatitis B virus activities of 5"-O-myristoyl analogue derivatives of 3"-fluoro-2",3"-dideoxythymidine (FLT) and 3"-azido-2",3"-dideoxythymidine (AZT).
Parang K; Wiebe LI; Knaus EE; Huang JS; Tyrrell DL
J Pharm Pharm Sci; 1998; 1(3):108-14. PubMed ID: 10948398
[TBL] [Abstract][Full Text] [Related]
38. Dipeptide model prodrugs for the intestinal oligopeptide transporter. Affinity for and transport via hPepT1 in the human intestinal Caco-2 cell line.
Nielsen CU; Andersen R; Brodin B; Frokjaer S; Taub ME; Steffansen B
J Control Release; 2001 Sep; 76(1-2):129-38. PubMed ID: 11532319
[TBL] [Abstract][Full Text] [Related]
39. Phenyl phosphotriester derivatives of AZT: variations upon the SATE moiety.
Villard AL; Coussot G; Lefebvre I; Augustijns P; Aubertin AM; Gosselin G; Peyrottes S; Périgaud C
Bioorg Med Chem; 2008 Aug; 16(15):7321-9. PubMed ID: 18585917
[TBL] [Abstract][Full Text] [Related]
40. In vitro evaluation of N-methyl amide tripeptidomimetics as substrates for the human intestinal di-/tri-peptide transporter hPEPT1.
Andersen R; Nielsen CU; Begtrup M; Jørgensen FS; Brodin B; Frokjaer S; Steffansen B
Eur J Pharm Sci; 2006 Jul; 28(4):325-35. PubMed ID: 16713701
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
